1. Introduction
===============

Since the 19th century, cod liver (CLO), for its source of vitamin D, has been used as one of the remedies to cure rickets \[[@B1-nutrients-06-04320]\]. It has been the most commonly used supplement in the UK for decades \[[@B2-nutrients-06-04320],[@B3-nutrients-06-04320],[@B4-nutrients-06-04320],[@B5-nutrients-06-04320],[@B6-nutrients-06-04320]\]. In EPIC-Norfolk, 32% of men and 45% of women used dietary supplements between 1993 and 1998 \[[@B7-nutrients-06-04320]\] with nearly 25% of all participants consuming CLO \[[@B8-nutrients-06-04320]\]. Special interest in CLO supplement use is warranted for several reasons. Firstly, for its nutrients, CLO contains eicosapentaenoic acid and docosahexaenoic acid, which in observational studies have been negatively associated with several cancer sites \[[@B9-nutrients-06-04320],[@B10-nutrients-06-04320]\]; on the other hand, meta-analyses of trial and/or cohort data have shown no effect of these omega-3 fatty acids in supplement form on cardiovascular disease \[[@B11-nutrients-06-04320],[@B12-nutrients-06-04320]\]. CLO also provides vitamins A, D and E of which vitamin D prevents osteomalacia and has been associated with osteoporosis \[[@B13-nutrients-06-04320]\]; while chronic intake above 1500 µg/day of vitamin A might increase the risk of fractures \[[@B14-nutrients-06-04320]\]. Secondly, methodological reasons: there is no such person as "a supplement user" \[[@B5-nutrients-06-04320],[@B15-nutrients-06-04320]\], supplement users (SU) are heterogeneous and ignoring these differences can lead to bias \[[@B16-nutrients-06-04320]\]. These differences are not only due to lifestyle \[[@B17-nutrients-06-04320]\], but also to what is referred to as "confounding by indication" \[[@B5-nutrients-06-04320],[@B18-nutrients-06-04320],[@B19-nutrients-06-04320]\]. Meaning that certain co-morbidities make the use of certain dietary supplements more likely, which, if not taken into account, could lead to the conclusion that there is an association between the exposure, *i.e.*, dietary supplements, and outcome (e.g., fracture) when in fact the co-morbidity (e.g., osteoporosis) is merely an indication for, or increases, supplement use.

Before public health messages can be formulated to encourage or discourage CLO use, also in the light of possible harmful effects when overdosed \[[@B20-nutrients-06-04320]\], a careful analysis of eating habits and other possible confounders in CLO consumers will have to precede this \[[@B16-nutrients-06-04320]\]. Supplement use in general in the United Kingdom \[[@B3-nutrients-06-04320],[@B4-nutrients-06-04320],[@B5-nutrients-06-04320],[@B21-nutrients-06-04320]\], Europe \[[@B22-nutrients-06-04320]\], the United States \[[@B23-nutrients-06-04320]\] and Australia \[[@B24-nutrients-06-04320],[@B25-nutrients-06-04320]\] has been associated with socio-demographic factors such as being a woman, being older, having a higher socio-economic status; behaviour-wise, SU exercise more, smoke less, eat more healthily and have a lower body mass index (BMI). Whether CLO consumers share the same characteristics as SU in general, and as a result would confound the association found between CLO consumption and health, requires further study. The high proportion of CLO consumers, as well as the detailed information collected in this aging cohort, puts EPIC-Norfolk in a position to study such associations.

This paper describes the socio-demographics, eating habits, anthropometry and self-reported health of NSU and SU in EPIC-Norfolk, with a special focus on the most commonly consumed supplement: CLO.

2. Methods
==========

2.1. Study Design and Participant Selection
-------------------------------------------

This study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures were approved by the Norfolk District Health Authority Ethics Committee. Written informed consent was obtained from all participants. The study started in 1993 with participants aged between 40 and 79 years. Participants lived in the Norfolk area of East Anglia and were recruited from general practitioners' (GP) age-sex registers \[[@B26-nutrients-06-04320]\]. Of the 77,630 invited participants, 30,447 gave their informed consent and received a Health and Lifestyle Questionnaire. Of this group, 25,639 attended a health examination at their GP-clinic and were given a 7-day Diet Diary (7dDD).

2.2. Data Collection
--------------------

The Health and lifestyle Questionnaire was sent to the participants in advance of their GP clinic appointment. Participants were asked about the following: smoking habits (never, former or current smoker); final level of education obtained (no qualifications, O-level, A-level, Degree or equivalent); current profession, from which socio-economic class was derived (unskilled, semi-skilled, skilled manual, skilled non-manual, managerial or professional); marital status (married, single, widowed, divorced or separated); a validated physical activity score combining occupational and recreational physical activity (active, moderately active, moderately inactive, inactive) \[[@B27-nutrients-06-04320]\]; and self-reported illnesses, such as cardiovascular diseases, diabetes, cancer and osteoporosis, measured by the question: "Has the doctor ever told you that you have any of the following". The participant's postcode was linked to the Townsend residential area deprivation score. This score identifies material deprivation by using four components: unemployment, non-car ownership, non-house ownership and overcrowding, *i.e.*, the number of people who live per room in a house \[[@B28-nutrients-06-04320]\].

Participants were taken through the research protocol by a trained nurse \[[@B26-nutrients-06-04320]\]. During the health examination, weight (kg) and height (cm) were measured from which Body Mass Index (BMI) was calculated (kg/m^2^).

A 7dDD was handed out at the health examination \[[@B29-nutrients-06-04320],[@B30-nutrients-06-04320]\]. This diary was a 45-page, A5 booklet, with detailed instructions regarding how food and drink should be recorded, as well as seventeen series of colour photos, depicting portions of food items on plates in increasing quantities. The nurse completed a 24-h diet recall as a means of instruction (*n* = 25,507; 99%). The remainder of the 7dDD was completed at the participant's home, 23,638 (92%) of the participants completed more than one day.

The 7dDD ended with general questions, referred to as the "Back Of Diary (BOD)", and was completed by 23,309 (91%) participants \[[@B8-nutrients-06-04320]\]. The BOD included the question relating to supplement use ("Please name any vitamins, minerals or other food supplements taken on each day of last week"). If this question was left open, crossed out or answered with "no/none", then participants were categorised as NSU; however, if participants had recorded any supplements taken, they were categorised as SU. Kappa-statistics with instruments recalling supplement use over the past year in EPIC-Norfolk ranged from 0.72--0.78 \[[@B7-nutrients-06-04320]\]. Supplements were coded according to the Vitamin and Minerals Supplement (ViMiS) system described in detail elsewhere \[[@B8-nutrients-06-04320]\]. Summarised, supplements were grouped into 45 distinct groups of which CLO was one. This group included CLO or any other type of fish oil, and CLO supplements combined with multivitamins or with, for example, evening primrose oil in the *same* capsule. For the purpose of this analysis, participants who reported medication containing vitamins and/or minerals without further supplement use were classified as NSU.

The 7dDD were entered by trained data-entry clerks using a program called DINER, Data Into Nutrients for Epidemiological Research \[[@B30-nutrients-06-04320]\] and checked and calculated by nutritionists using DINERMO \[[@B31-nutrients-06-04320]\]. Alcohol intake in grams was divided by 8 to obtain the number of units in alcoholic beverages. Food group data were calculated by summing the weight of each food item consumed, belonging to either fruit, vegetables, red, white or processed meat or white and fatty fish, as well as the percentage contribution to these food groups from composite food items (e.g., Beef stew including vegetables) \[[@B31-nutrients-06-04320]\]. These food groups were chosen because of established associations with cancer and cardiovascular risk factors \[[@B32-nutrients-06-04320]\].

2.3. Statistical Analysis
-------------------------

The characteristics of participants were compared using two different groupings. First, NSU *vs.* SU, followed by two SU subgroups in order to elucidate possible confounding factors for CLO users: SU+CLO, participants who used CLO *or* supplements where cod liver oil/fish oil was an ingredient, also when used in combination with non-CLO supplements (*i.e.*, multiple supplement users of which at least one contained CLO); SU-CLO, participants who consumed one or more supplements that did not contain CLO.

Both comparisons were firstly carried out without adjustment, stratified by sex, using the Chi-squared statistic, followed by multivariable binary (SU *vs.* NSU) and multinomial (SU+CLO *vs.* NSU and SU-CLO *vs.* NSU) logistic regression to compare these groups adjusted for all presented socio-demographic variables.

Differences in food consumption between NSU and SU groups were tested using the Mann-Whitney U and Kruskal-Wallis statistic. Associations between self-reported illnesses and supplement use were adjusted for age using multinomial logistic regression, with supplement use as the dependent variable (NSU/SU+CLO/SU-CLO). Analyses were performed using SPSS v19 (IBM Corp., Armonk, NY, USA). *p*-values below 0.05 were considered significant.

3. Results
==========

3.1. Supplement Consumption
---------------------------

Out of 23,039 participants who answered the BOD, 3253 (31.7%) of men (*n* = 10,247) and 5736 (44.8%) of women (*n* = 12,792) used a supplement (χ^2^ (1) = 410.01, *p* \< 0.001). A total of 5262 and 10,732 supplements were consumed by men and women respectively. For both men and women, CLO was the most commonly consumed supplement (43% and 32% respectively), followed by garlic (12%) and multivitamins (11%) for men and multivitamins (11%) and evening primrose oil (10%) for women. For CLO supplements, 94% of men and 96% of women used these on a daily basis compared to 89% and 90% respectively for non-CLO supplements. CLO supplements were consumed by 22% of men and 26% of women. Only 10% of men consumed supplements that did not contain CLO, compared to 19% of women.

3.2. Socio-Demographic Characteristics of Supplement Users
----------------------------------------------------------

Supplement use in general was associated with sex-dependent characteristics (see columns NSU and SU in [Table 1](#nutrients-06-04320-t001){ref-type="table"} for men and [Table 2](#nutrients-06-04320-t002){ref-type="table"} for women). Male SU were older than NSU, whereas female SU completed higher levels of education than female NSU. Marital status was not, and Townsend score only weakly, associated with supplement use. All other characteristics had, in general, stronger associations among women compared to men. In summary, supplement use indicated a healthier lifestyle and higher socio-economic class.

The characteristics of the participants who consumed a supplement that contained CLO (SU+CLO) *vs.* NSU and participants who consumed other types of supplements (SU-CLO) *vs.* NSU (see [Table 1](#nutrients-06-04320-t001){ref-type="table"} and [Table 2](#nutrients-06-04320-t002){ref-type="table"}), resulted in stronger associations with socio-demographic characteristics with supplement use, especially among women. Notably, younger age in women was strongly associated with the SU-CLO category, similarly for higher education level; however, such associations among SU+CLO were not present. In men, not being married as well as a higher education level, though not associated with supplement use in general, was associated with SU-CLO.

Results of the fully adjusted analysis (NSU *vs.* SU) are to be found in [Table 1](#nutrients-06-04320-t001){ref-type="table"} and [Table 2](#nutrients-06-04320-t002){ref-type="table"} (see column SU *vs.* NSU). 3.6% of the participants were lost due to missing values for one or more variables (*n* = 22,205). For supplement use in general, results remained the same as in the unadjusted analysis, except for the area deprivation score in both sexes. Smoking had the strongest association with supplement use, decreasing the odds of supplement use with 41% in men and 29% in women; followed by physical inactivity in men and winter season and lower social class in women. The analysis was repeated with sex in the model (data not shown) and showed a significant independent effect of sex on supplement use in general (OR = 0.54; 95% CI: 0.51--0.58).

Multinomial logistic regression compared NSU with the two SU subgroups (SU+CLO and SU-CLO, see last two columns in [Table 1](#nutrients-06-04320-t001){ref-type="table"} and [Table 2](#nutrients-06-04320-t002){ref-type="table"}). Results were similar compared to the unadjusted analysis, with exception of education level among men and area deprivation score in both sexes, which lost their significance. Strongest associations were again seen for current smoking; other variables, particularly social class and education, were more strongly associated with the SU-CLO group and not with the SU+CLO group when compared to supplement use in general.

nutrients-06-04320-t001_Table 1

###### 

Characteristics of European Prospective Investigation into Cancer (EPIC)-Norfolk participants (men only) according to supplement status (Non-supplement User (NSU)/Supplement User (SU)) and supplement subgroup (NSU/SU+cod liver oil (CLO)/SU-CLO). Analyses are shown unadjusted (Chi-squared test). Logistic regression (NSU/SU) and multinomial logistic regression (NSU/SU+CLO/SU-CLO) were adjusted for all variables in this table (*n* = 9943). Boldly printed OR were statistically significant findings.

  *MEN*                    *NSU N*                           *%*                               *SU N*   *%*    *SU+CLO N*   *%*    *SU-CLO N*   *%*    *SU vs. NSU OR*                               *95% CI*     *SU+CLO vs. NSU OR*   *95% CI*     *SU-CLO vs. NSU OR*   *95% CI*
  ------------------------ --------------------------------- --------------------------------- -------- ------ ------------ ------ ------------ ------ --------------------------------------------- ------------ --------------------- ------------ --------------------- ------------
  Age                      6994                                                                3253            2215                1038                                                                                                                                    
   \<=50 years             1696                              24.2                              528      16.2   285          12.9   243          23.4   **1.15**                                      1.12--1.18   **1.21**              1.17--1.24   **1.05**              1.01--1.09
   \>50--60 years          2199                              31.4                              950      29.2   649          29.3   301          29.0   OR represents the % change in odds of being                                                                         
   \>60--70 years          2120                              30.3                              1218     37.4   876          39.5   342          32.9   a SU for every 5 year increment in age                                                                              
   \>70 years              979                               14.0                              557      17.1   405          18.3   152          14.6                                                                                                                       
                           χ^2^ (3) = 118.51, *p* \< 0.001   χ^2^ (6) = 170.43, *p* \< 0.001                                                                                                                                                                               
  Marital status           6967                                                                3227            2198                1029                                                                                                                                    
   Married                 6110                              87.7                              2839     88.0   1956         89.0   883          85.8   Ref                                                        Ref                                Ref                   
   Not married ^a^         857                               12.3                              388      12.0   242          11.0   146          14.2   1.01                                          0.88--1.15   0.88                  0.75--1.03   **1.30**              1.07--1.58
                           χ^2^ (1) = 0.16, n.s.             χ^2^ (2) = 6.76, *p* \< 0.05                                                                                                                                                                                  
  Social class             6881                                                                3197            2174                1023                                                                                                                                    
   Non-Manual ^b^          3935                              57.2                              1961     61.3   1265         58.2   696          68.0   Ref                                                        Ref                                Ref                   
   Manual ^c^              2946                              42.8                              1236     38.7   909          41.8   327          32.0   **0.87**                                      0.79--0.95   1.00                  0.90--1.11   **0.63**              0.55--0.74
                           χ^2^ (1) = 15.50, *p* \< 0.001    χ^2^ (2) = 43.29, *p* \< 0.001                                                                                                                                                                                
  Education level          6991                                                                3249            2211                1038                                                                                                                                    
   Any qualification ^d^   4829                              69.1                              2276     70.1   1508         68.2   768          74.0   Ref                                                        Ref                                Ref                   
   No qualifications       2162                              30.9                              973      29.9   703          31.8   270          26.0   0.93                                          0.84--1.03   0.95                  0.84--1.06   0.89                  0.76--1.05
                           χ^2^ (1) = 1.00, n.s.             χ^2^ (2) = 12.12, *p* \< 0.01                                                                                                                                                                                 
  Townsend index ^e^       6968                                                                3245            2211                1034                                                                                                                                    
   Score \< 0              5859                              84.1                              2786     85.9   1910         86.4   876          84.7   Ref                                                        Ref                                Ref                   
   Score \> 0              1109                              15.9                              459      14.1   301          13.6   158          15.3   0.93                                          0.82--1.05   0.88                  0.76--1.02   1.04                  0.86--1.26
                           χ^2^ (1) = 5.34, *p* \< 0.05      χ^2^ (2) = 6.85, *p* \< 0.05                                                                                                                                                                                  
  Smoking                  6951                                                                3226            2197                1029                                                                                                                                    
   Never                   2295                              33.0                              1111     34.4   730          33.2   381          37.0   Ref                                                        Ref                                Ref                   
   Former                  3756                              54.0                              1872     58.0   1309         59.6   563          54.7   0.95                                          0.87--1.05   0.97                  0.87--1.08   0.91                  0.79--1.05
   Current                 900                               12.9                              243      7.5    158          7.2    85           8.3    **0.59**                                      0.50--0.69   **0.58**              0.48--0.70   **0.61**              0.47--0.79
                           χ^2^ (2) = 65.22, *p* \< 0.001    χ^2^ (4) = 71.95, *p* \< 0.001                                                                                                                                                                                
  Physical activity ^f^    6991                                                                3249            2211                1038                                                                                                                                    
   (Moderately) active     3060                              43.8                              1475     45.4   1000         45.2   475          45.8   Ref                                                        Ref                                Ref                   
   (Moderately) inactive   3931                              56.2                              1774     54.6   1211         54.8   563          54.2   **0.82**                                      0.75--0.90   **0.82**              0.74--0.91   **0.81**              0.71--0.93
                           χ^2^ (1) = 2.38, n.s.             χ^2^ (2) = 2.46, n.s.                                                                                                                                                                                         
  Start 7dDD ^g^           6994                                                                3252            2215                1037                                                                                                                                    
   Spring/Summer           3507                              50.1                              1541     47.4   1066         48.1   475          45.8   Ref                                                        Ref                                Ref                   
   Autumn/Winter           3487                              49.9                              1711     52.6   1149         51.9   562          54.2   **1.12**                                      1.03--1.22   1.09                  0.98--1.20   **1.20**              1.05--1.37
                           χ^2^ (1) = 6.75, *p* \< 0.01      χ^2^ (2) = 8,27, *p* \< 0.05                                                                                                                                                                                  

NSU, Non-supplement User; SU, Supplement User; CLO, cod liver oil; χ^2^, Chi-squared test; OR, odds ratio; CI, confidence interval; Ref, Reference category. ^a^ Not married included the categories (NSU/SU): single (*n* = 290/128), widowed (*n* = 213/106), separated (*n* = 69/19) and divorced (*n* = 286/135); ^b^ Non-manual included the categories (NSU/SU): professional (*n* = 544/222), managerial (*n* = 2531/1315), skilled non-manual (*n* = 860/424); ^c^ Manual included the categories (NSU/SU): skilled manual (*n* = 1787/760), semi-skilled (*n* = 934/397) and non-skilled (*n* = 225/79); ^d^ Any qualification included (NSU/SU): O-level (*n* = 587/291), A-level (*n* = 3177/1518), Degree or equivalent (*n* = 1065/467); ^e^ Townsend index score \< 0 means district in which the participant lives is more affluent than the mean in England; score \> 0 means a district in which the participant lives is more deprived than the mean in England; ^f^ Included the categories (NSU/SU): active (1467/705), moderately active (1593/770), moderately inactive (1685/837), inactive (2246/937); ^g^ Created from first date in the diary; Spring: March-May, Summer: June-August, Autumn: September-November, Winter: December-February.

nutrients-06-04320-t002_Table 2

###### 

Characteristics of EPIC-Norfolk participants (women only) according to supplement status (NSU/SU) and supplement subgroup (NSU/SU+CLO/SU-CLO). Analysis are shown unadjusted (Chi-squared test). Logistic regression (NSU/SU) and multinomial logistic regression (NSU/SU+CLO/SU-CLO) were adjusted for all variables in this table *(n* = 12,262). Boldly printed OR were statistically significant findings.

  *WOMEN*                  *NSU N*                         *%*                              *SU N*   *%*    *SU+CLO N*   *%*    *SU-CLO N*   *%*    *SU vs. NSU OR*                               *95% CI*     *SU+CLO vs. NSU OR*   *95% CI*     *SU-CLO vs. NSU OR*   *95% CI*
  ------------------------ ------------------------------- -------------------------------- -------- ------ ------------ ------ ------------ ------ --------------------------------------------- ------------ --------------------- ------------ --------------------- ------------
  Age                      7056                                                             5736            3389                2347                                                                                                                                    
   \<=50 years             1833                            26.0                             1356     23.6   611          18.0   745          31.7   1.02                                          1.00--1.04   **1.09**              1.06--1.12   **0.93**              0.90--0.95
   \>50--60 years          2185                            31.0                             1862     32.5   1107         32.7   755          32.2   OR represents the % change in odds of being                                                                         
   \>60--70 years          2100                            29.8                             1792     31.2   1170         34.5   622          26.5   a SU for every 5 year increment in age                                                                              
   \>70 years              938                             13.3                             726      12.7   501          14.8   225          9.6                                                                                                                        
                           χ^2^ (3) = 12.43 *p* \< 0.01    χ^2^ (6) = 175.26 *p* \< 0.001                                                                                                                                                                               
  Marital status           7025                                                             5691            3363                2328                                                                                                                                    
   Married                 5400                            76.9                             4315     75.8   2519         74.9   1796         77.1   Ref                                                        Ref                                Ref                   
   Not married ^a^         1625                            23.1                             1376     24.2   844          25.1   532          22.9   1.06                                          0.98--1.16   1.06                  0.96--1.17   1.06                  0.94--1.20
                           χ^2^ (1) = 1.91 n.s.            χ^2^ (2) = 5.75 n.s.                                                                                                                                                                                         
  Social class             6865                                                             5612            3299                2313                                                                                                                                    
   Non-Manual ^b^          4063                            59.2                             3610     64.3   2049         62.1   1561         67.5   Ref                                                        Ref                                Ref                   
   Manual ^c^              2802                            40.8                             2002     35.7   1250         37.9   752          32.5   **0.84**                                      0.78--0.91   **0.90**              0.82--0.99   **0.76**              0.69--0.85
                           χ^2^ (1) = 34.48 *p* \< 0.001   χ^2^ (2) = 51.09 *p* \< 0.001                                                                                                                                                                                
  Education level          7052                                                             5732            3386                2346                                                                                                                                    
   Any qualification ^d^   3942                            55.9                             3423     59.7   1869         55.2   1554         66.2   Ref                                                        Ref                                Ref                   
   No qualifications       3110                            44.1                             2309     40.3   1517         44.8   792          33.8   **0.91**                                      0.84--0.99   1.02                  0.93--1.11   **0.77**              0.69--0.86
                           χ^2^ (1) = 18.88 *p* \< 0.001   χ^2^ (2) = 88.08 *p* \< 0.001                                                                                                                                                                                
  Townsend index ^e^       7030                                                             5710            3375                2335                                                                                                                                    
   Score \<0               5845                            83.1                             4845     84.9   2851         84.5   1994         85.4   Ref                                                        Ref                                Ref                   
   Score \>0               1185                            16.9                             865      15.1   524          15.5   341          14.6   0.91                                          0.82--1.01   0.91                  0.81--1.02   0.91                  0.80--1.05
                           χ^2^ (1) = 6.80 *p* \< 0.01     χ^2^ (2) = 7.67 *p* \< 0.05                                                                                                                                                                                  
  Smoking                  6992                                                             5680            3350                2330                                                                                                                                    
                                                                                                                                                                                                                                                                        
   Never                   3.949                           56.5                             3260     57.4   1939         57.9   1321         56.7   Ref                                                        Ref                                Ref                   
   Former                  2179                            31.2                             1930     34.0   1162         34.7   768          33.0   1.08                                          1.00--1.17   1.07                  0.98--1.17   1.09                  0.98--1.21
   Current                 864                             12.4                             490      8.6    249          7.4    24           10.3   **0.71**                                      0.63--0.80   **0.61**              0.53--0.72   **0.85**              0.72--0.99
                           χ^2^ (2) = 48.93 *p* \< 0.001   χ^2^ (4) = 61.43 *p* \< 0.001                                                                                                                                                                                
  Physical activity ^f^    7052                                                             5732            3386                2346                                                                                                                                    
   (Moderately) active     2561                            36.3                             2259     39.4   1282         37.9   977          41.6   Ref                                                        Ref                                Ref                   
   (Moderately) inactive   4491                            63.7                             3473     60.6   2104         62.1   1369         58.4   **0.87**                                      0.80--0.94   **0.87**              0.80--0.96   **0.86**              0.77--0.95
                           χ^2^ (1) = 12.89 *p* \< 0.001   χ^2^ (2) = 21.34 *p* \< 0.001                                                                                                                                                                                
  Start 7dDD ^g^           7056                                                             5736            3389                2347                                                                                                                                    
   Spring/Summer           3662                            51.9                             2765     48.2   1640         48.4   1125         47.9   Ref                                                        Ref                                Ref                   
   Autumn/Winter           3394                            48.1                             2971     51.8   1749         51.6   1222         52.1   **1.16**                                      1.08--1.25   **1.15**              1.06--1.26   **1.17**              1.07--1.29
                           χ^2^ (1) = 17.28 *p* \< 0.001   χ^2^ (2) = 17.39 *p* \< 0.001                                                                                                                                                                                

NSU, Non-supplement User; SU, Supplement User; CLO, cod liver oil; χ ^2^, Chi-squared test; CI, confidence interval; Ref, Reference category. ^a^ Not married includes the categories (NSU/SU): single (*n* = 281/230), widowed (*n* = 806/670), separated (*n* = 67/65) and divorced (*n* = 471/411); ^b^ Non-manual includes the categories (NSU/SU): professional (*n* = 421/372), managerial (*n* = 2343/2026), skilled non-manual (*n* = 1299/1212); ^c^ Manual includes the categories (NSU/SU): skilled manual (*n* = 1511/1115), semi-skilled (*n* = 971/702) and non-skilled (*n* = 320/185); ^d^ Any qualification included (NSU/SU): O-level (*n* = 830/640), A-level (*n* = 2363/2163), Degree or equivalent (*n* = 749/620); ^e^ Townsend index score \< 0 means district in which the participant lives is more affluent than the mean in England; score \> 0 means a district in which the participant lives is more deprived than the mean in England; ^f^ Included the categories (NSU/SU): active (1012/954), moderately active (1549/1305), moderately inactive (2186/1924), inactive (2305/1549); ^g^ Created from first date in the diary; Spring: March-May, Summer: June-August, Autumn: September-November, Winter: December-February.

3.3. Food Choices of Supplement Users
-------------------------------------

SU in general consumed significantly more fruit, vegetables and fatty fish and less red and processed meat than NSU ([Table 3](#nutrients-06-04320-t003){ref-type="table"}). In both men and women, the lower intake of red and processed meats amongst SU in general appeared to be mainly driven by the SU-CLO group, which had a significantly lower intake compared to the SU+CLO group (*p* \< 0.025). Although there were no associations between alcohol consumption and supplement use in men, we observed a higher proportion of alcohol consumers among women using supplements, particularly the SU-CLO group, as well as an increment in their median weekly intake (*p* \< 0.025).

3.4. Health and Supplement Use
------------------------------

BMI was associated with both age and supplement use. The mean (95% CI), age-adjusted BMI for male NSU was 26.6 (26.5--26.7) kg/m^2^, for SU+CLO 26.3 (26.2--26.4) kg/m^2^ and for SU-CLO 26.1 (25.9--26.2) kg/m^2^ (F = 15.6 \[2;10217\], *p* \< 0.001). Among women, the association between supplement use and BMI was stronger; the mean BMI for female NSU was 26.4 (26.3--26.5) kg/m^2^, for SU+CLO 25.9 (25.7--26.0) kg/m^2^ and for SU-CLO 25.6 (25.4--25.8) kg/m^2^ (F = 42.4 \[2;12750\], *p* \< 0.001).

In this *cross-sectional* study, the use of different types of dietary supplements was associated with self-reported illnesses ([Table 4](#nutrients-06-04320-t004){ref-type="table"}). For participants who reported having had benign growths, the odds of being a SU-CLO increased by 36% in men and 35% in women compared to NSU. Diseases affecting the heart and circulation were *negatively* associated with CLO supplement use and not associated with non-CLO supplement use. Men who reported having had a heart attack had a 42% lower odds of using CLO compared to men free of a prevalent heart attack; women who reported having been diagnosed with diabetes had a 50% reduced odds of being a SU+CLO. Participants who reported diseases that affect bone health were reporting more supplement use. Women who reported arthritis had a 60% increased odds of using CLO and 15% increased use of other types of supplements; similar results for CLO use were found for men. Women who reported osteoporosis had a 58% increased odds of using a non-CLO supplement.

nutrients-06-04320-t003_Table 3

###### 

Comparison of food group intake distributions between Non-Supplement Users and Supplement Users (NSU/SU) and between SU subgroups (NSU/SU+CLO/SU-CLO) in the EPIC-Norfolk study.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Food groups*                              *NSU Median*   *IQR*       *SU Median*   *IQR*       *SU+CLO Median*   *IQR*       *SU-CLO Median*   *IQR*       *p-value ^a^*\   *p-value ^b^*\
                                                                                                                                                              *NSU vs. SU*     *NSU vs. SU+CLO vs. SU-CLO*
  ------------------------------------------ -------------- ----------- ------------- ----------- ----------------- ----------- ----------------- ----------- ---------------- -----------------------------
  MEN (n)                                    6994                       3252                      2215                          1037                                           

  Fruit (g/day)                              127            60--212     161           86--253     161               89--257     158               79--244     *p* \< 0.001     *p* \< 0.001

  Vegetables (g/day)                         139            99--188     145           106--198    146               108--197    145               102--202    *p* \< 0.001     *p* \< 0.001

  Meat                                                                                                                                                                         

  Red (g/day)                                38             20--59      33            16--54      \*34              16--55      31                14--52      *p* \< 0.001     *p* \< 0.001

  White (g/day)                              22             7--40       22            7--40       22                8--40       21                6--40       n.s.             n.s.

  Processed (g/day)                          25             13--40      22            11--37      \*23              12--38      21                9--35       *p* \< 0.001     *p* \< 0.001

  Fish                                                                                                                                                                         

  White(g/day)                               16             0--25       16            0--27       16                0--27       15                0--27       *p* \< 0.01      *p* \< 0.01

  Fatty (g/day)                              1              0--19       8             0--24       7                 0--24       8                 0--24       *p* \< 0.001     *p* \< 0.001

  Alcoholic beverages (units/diary)          8.1            1.2--21.0   8.2           1.2--21.1   8.1               1.3--20.9   8.4               0.9--21.8   n.s.             n.s.

  Alcohol consumers only (units/diary) ^c^   13.0           5.3--25.5   13.0          5.4--25.5   12.8              5.1--25.1   13.9              6.0--26.8   n.s.             n.s.

  WOMEN (n)                                  7056                       5736                      3389                          2347                                           

  Fruit (g/day)                              151            83--238     180           107--267    \*183             110--269    174               104--263    *p* \< 0.001     *p* \< 0.001

  Vegetables (g/day)                         136            97--183     145           107--194    145               108--192    146               105--197    *p* \< 0.001     *p* \< 0.001

  Meat                                                                                                                                                                         

  Red (g/day)                                27             12--45      24            9--41       \*25              10--42      23                7--40       *p* \< 0.001     *p* \< 0.001

  White (g/day)                              18             5--34       19            6--35       19                5--36       19                6--35       *p* \< 0.05      n.s.

  Processed (g/day)                          16             7--27       14            6--25       \*15              6--25       14                4--24       *p* \< 0.001     *p* \< 0.001

  Fish                                                                                                                                                                         

  White (g/day)                              12             0--21       12            0--22       \*13              0--23       11                0--21       n.s.             *p* \< 0.001

  Fatty (g/day)                              3              0--16       6             0--20       6                 0--21       6                 0--19       *p* \< 0.001     *p* \< 0.001

  Alcoholic beverages (units/diary)          2.1            0.0--9.2    3.3           0--10.3     \*3.1             0.0--9.8    3.9               0.0--11.2   *p* \< 0.001     *p* \< 0.001

  Alcohol consumers only (units/diary) ^d^   6.9            3.0--14.6   7.3           3.3--14.7   \*7.0             3.2--14.1   7.7               3.5--15.2   n.s.             *p* \< 0.05
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NSU, Non-supplement User; SU, Supplement User; CLO, cod liver oil; IQR, Inter Quartile Range. ^a^ Differences between groups tested using Mann-Whitney U test; ^b^ Differences between groups tested using Kruskal-Wallis test and if significant, followed by Mann-Whitney U test to test for differences in SU subgroups. *p*-values \< 0.025 were considered significant (Bonferroni correction applied: 0.05/2, marked with an \* in the SU+CLO column); ^c^ Men: NSU *n* = 5411 (77%), SU+CLO *n* = 1748 (79%), SU-CLO *n* = 799 (77%); ^d^ Women: NSU *n* = 4352 (62%) , SU+CLO *n* = 2233 (66%), SU-CLO *n* = 1611 (69%); \* *p*-value \< 0.025 (see also footnote b).

nutrients-06-04320-t004_Table 4

###### 

Differences in self-reported health between non-supplement users (NSU) and supplement user subgroups (SU+CLO, SU-CLO) in EPIC-Norfolk.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Health condition*    *Answer category*   *N*      *%*    *NSU N*   *%*    *SU+CLO N*   *%*    *SU-CLO N*   *%*    *SU+CLO vs NSU*\   *95% C.I.*   *SU-CLO vs. NSU*\   *95% C.I.*
                                                                                                                     *OR ^a^*                        *OR ^a^*            
  --------------------- ------------------- -------- ------ --------- ------ ------------ ------ ------------ ------ ------------------ ------------ ------------------- ------------
  MEN                                       10,247          6994      68.3   2215         21.6   1038         10.1                                                       

  Mean age (SD)                                             58.9      9.3    61.8         8.6    59.4         9.3    **1.19**           1.16--1.22   1.03                0.99--1.07

  Benign growth         Yes                 993      9.7    634       9.1    234          10.6   125          12.1   1.12               0.96--1.32   **1.36**            1.11--1.67

                        No                  9235     90.3   6348      90.9   1975         89.4   912          87.9   Ref                             Ref                 

  Cancer                Yes                 405      4.0    259       3.7    94           4.3    52           5.0    0.98               0.76--1.24   1.33                0.98--1.89

                        No                  9830     96.0   6727      96.3   2117         95.7   986          95.0   Ref                             Ref                 

  Heart attack          Yes                 560      5.5    409       5.9    94           4.3    57           5.5    **0.58**           0.46--0.74   0.90                0.68--1.20

                        No                  9668     94.5   6573      94.1   2116         95.7   979          94.5   Ref                             Ref                 

  Stroke                Yes                 189      1.8    139       2.0    36           1.6    14           1.4    **0.65**           0.45--0.94   0.64                0.37--1.12

                        No                  10,041   98.2   6846      98.0   2173         98.4   1022         98.6   Ref                             Ref                 

  High blood pressure   Yes                 1469     14.4   979       14.0   328          14.9   162          15.6   0.92               0.80--1.05   1.11                0.92--1.33

                        No                  8753     85.6   5999      86.0   1879         85.1   875          84.4   Ref                             Ref                 

  Diabetes              Yes                 333      3.3    236       3.4    69           3.1    28           2.7    0.78               0.59--1.03   0.77                0.52--1.14

                        No                  9898     96.7   6747      96.6   2141         96.9   1010         97.3   Ref                             Ref                 

  Arthritis             Yes                 1932     18.9   1137      16.3   604          27.4   191          18.5   **1.72**           1.53--1.93   1.14                0.96--1.35

                        No                  8282     81.1   5837      83.7   1602         72.6   843          81.5   Ref                             Ref                 

  Osteoporosis          Yes                 60       0.6    42        0.6    12           0.5    6            0.6    0.75               0.39--1.43   0.93                0.39--2.19

                        No                  10,166   99.4   6940      99.4   2194         99.5   1032         99.4   Ref                             Ref                 

                                                                                                                                                                         

  WOMEN                                     12792           7056      55.2   3389         26.5   18.3         2347                                                       

  Mean age (SD)                                             58.6      9.4    60.0         8.8    56.9         9.2    **1.09**           1.07--1.12   **0.91**            0.88--0.93

  Benign growth         Yes                 2448     19.2   1227      17.4   703          20.8   518          22.1   **1.25**           1.12--1.38   **1.35**            1.21--1.52

                        No                  10,304   80.8   5812      82.6   2671         79.2   1821         77.9   Ref                             Ref                 

  Cancer                Yes                 883      6.9    468       6.6    258          7.6    157          6.7    1.11               0.94--1.30   1.07                0.89--1.30

                        No                  11,898   93.1   6582      93.4   3127         92.4   2189         93.3   Ref                             Ref                 

  Heart attack          Yes                 168      1.3    105       1.5    39           1.2    24           1.0    **0.66**           0.46--0.96   0.82                0.52--1.28

                        No                  12,608   98.7   6941      98.5   3345         98.8   2322         99.0   Ref                             Ref                 

  Stroke                Yes                 127      1.0    86        1.2    26           0.8    15           0.6    **0.55**           0.35--0.86   0.61                0.35--1.06

                        No                  12,651   99.0   6962      98.8   3358         99.2   2331         99.4   Ref                             Ref                 

  High blood pressure   Yes                 1840     14.4   1067      15.1   483          14.3   290          12.4   **0.84**           0.74--0.94   0.89                0.77--1.03

                        No                  10,926   85.6   5977      84.9   2899         85.7   2050         87.6   Ref                             Ref                 

  Diabetes              Yes                 205      1.6    139       2.0    37           1.1    29           1.2    **0.50**           0.35--0.73   0.69                0.46--1.03

                        No                  12,571   98.4   6908      98.0   3347         98.9   2316         98.8   Ref                             Ref                 

  Arthritis             Yes                 3495     27.4   1717      24.4   1195         35.4   583          25.0   **1.60**           1.46--1.76   **1.15**            1.03--1.28

                        No                  9247     72.6   5316      75.6   2180         65.6   1751         75.0   Ref                             Ref                 

  Osteoporosis          Yes                 340      2.7    164       2.3    100          3.0    76           3.2    1.17               0.91--1.51   **1.58**            1.20--2.09

                        No                  12,418   97.3   6877      97.7   3276         97.0   2265         96.8   Ref                             Ref                 
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NSU, Non-supplement User; SU, Supplement User; CLO, cod liver oil; OR, odds ratio, CI, confidence interval. ^a^ Age-adjusted OR (per 5 year) using multinomial logistic regression. Boldly printed OR were statistically significant findings.

4. Discussion
=============

Supplement use in EPIC-Norfolk is more prevalent among women and is associated with not smoking, a higher social class, higher physical activity levels and more favourable eating habits. These SU characteristics were found to be stronger for subgroups of SU, than for SU in general. Moreover, a participant's self-report of medical conditions at baseline was associated with subgroups of supplements, with CLO supplements being strongly positively associated with arthritis and negatively associated with cardiovascular conditions.

The associations found between supplement use in general and socio-demographic variables are in line with previous findings from a UK survey and cohort studies \[[@B4-nutrients-06-04320],[@B5-nutrients-06-04320],[@B21-nutrients-06-04320]\]. Our finding of more and stronger associations in women compared to men, has also been observed in the MRC National Survey of Health and Development \[[@B4-nutrients-06-04320]\]. However, important socio-demographic differences exist within SU. For example, in our study social class appeared to be mainly associated with SU-CLO use in men and women's education was only associated with SU-CLO use and not SU+CLO use. Also, while most "unhealthy behaviours" were less prevalent among SU, exceptions were smoking and alcohol consumption among women in the SU-CLO group. The Norwegian Women and Cancer (NoWAC) study grouped participants into categories by frequency of consumption of CLO use \[[@B33-nutrients-06-04320]\]. Their average age of 45 years was 15 years lower than in EPIC-Norfolk; even so, participants' age was positively associated with daily CLO consumption, as well as being an ex-smoker and being more physically active. Again, this stresses the different possible confounders within subgroups of SU.

In EPIC-Norfolk, SU, particularly the SU+CLO group, were found to have a higher consumption of fruit, vegetables and fatty fish and especially the SU-CLO group had a lower consumption of red and processed meat compared to NSU. These associations are comparable with other studies \[[@B4-nutrients-06-04320],[@B5-nutrients-06-04320],[@B21-nutrients-06-04320],[@B33-nutrients-06-04320]\] and are indicative that SU are a group of people who are least likely to need supplements. Although SU have in general been characterised as "healthy eating" consumers, this might not necessarily be so \[[@B15-nutrients-06-04320],[@B34-nutrients-06-04320]\]. A longitudinal study in Switzerland found that 21% of daily/weekly vitamin and mineral SU were clustered around a "healthy" food pattern (16% among NSU); whereas 31% of daily/weekly vitamin and mineral SU consumed an "unhealthy" food pattern (compared to 39% in NSU); the SU were also found to have the most positive attitude towards fortification and could have used supplements as a means of compensation. In the current analysis, only a limited set of foods were compared between NSU and SU in order to avoid multiple testing, but future analyses could compare clusters of a greater variety of foods.

In this cross-sectional analysis, participants who reported having had benign growths were more likely to report non-CLO supplement use. Cancer was not associated with supplement use in the EPIC-Norfolk study, contrary to what has been found in the UK Women's Cohort Study \[[@B35-nutrients-06-04320]\]. Also the VITAL cohort \[[@B18-nutrients-06-04320]\] reports significant associations between high dose vitamin E and cancer in women as well as a study among cancer survivors \[[@B36-nutrients-06-04320]\], where only vitamin use, but not mineral, herbal or other types of supplement use, was associated with cancer. In the VITAL cohort, the number of supplements consumed among women with a medical condition was higher than in men; however, the associations between supplement use and medical conditions were stronger in *men* \[[@B18-nutrients-06-04320]\]. It was suggested that women might use supplements to prevent illness, whereas men might start to take supplements after diagnosis. In EPIC-Norfolk, the associations between supplement use and medical conditions were of similar strength for men and women, but data collected at later health examinations will be able to answer important questions related to the onset of illness and the starting or stopping of supplement use. Although the time between diagnosis and the start of the use of dietary supplements is also of importance since participants might make a change in their habits shortly after diagnosis, but return to their former habits after some time has passed \[[@B36-nutrients-06-04320]\], the surveys in EPIC-Norfolk might not be frequent enough to capture these changes.

A limitation of our analysis is the stratification of results into SU+CLO and SU-CLO groups, since this is likely to have underestimated the heterogeneity among the SU-CLO subgroup. A recent analysis of the Hertfordshire Cohort Study (HCS) used cluster analysis to describe five groups of SU; however, plant and fish oils were grouped together \[[@B15-nutrients-06-04320]\]. The aim of our analysis was to study possible confounding variables of participants consuming fish and CLO supplements. SU+CLO reported more illnesses such as arthritis and less (symptoms of) cardiovascular disease and stroke, contrary to what is reported in the HCS \[[@B15-nutrients-06-04320]\]. A UK survey \[[@B5-nutrients-06-04320]\] and a survey among 65-98 year old Australians \[[@B24-nutrients-06-04320],[@B25-nutrients-06-04320]\] however found similar associations to EPIC-Norfolk. The data collected at later health examinations, will have to be taken into account before causal inferences between CLO and cardiovascular diseases can be made, especially since meta-analyses have not shown benefits \[[@B11-nutrients-06-04320],[@B12-nutrients-06-04320]\]. The fact that CLO is positively associated with age, and that it is more likely to be taken on a daily basis, makes the SU+CLO subgroup of particular interest to investigate further since exposure to CLO is likely to have been for an extended period of time and follow-up time in this prospective cohort is by now two decades, contrary to trials. The nutrients of these supplements are quantified in the ViMiS database where missing values for omega-3 fatty acids were completed, and units of measure were made compatible for food and supplement sources enabling the calculation of a "total nutrient exposure" in a detailed way \[[@B8-nutrients-06-04320],[@B37-nutrients-06-04320]\]. The wide range of endpoints collected will enable us to look at potential positive as well as harmful effects of CLO.

5. Conclusions
==============

Significant socio-demographic associations were found in this study with weaker and fewer associations in SU+CLO than in SU-CLO group, especially among men. Associations between supplement use and age, smoking, social class and education were strong, but not uniform across all SU or between sexes. Participants, who had prevalent heart attack or stroke, were less likely to report CLO supplements; however, self-reported arthritis was associated with increased CLO use. The differences we found between subgroups of SU provide important information that will be necessary for later endpoint analysis of this and other studies, since confounding by indication as well as lifestyle confounders will need to be taken into account depending on the type of supplement consumed.
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